The Transferability of Health Technology Assessment: The European Perspective with Focus on Central and Eastern European Countries

Bertalan Németh*, Wim Goettsch, Finn Børlum Kristensen, Oresta Piniazhko, Mirjana Huić, Tomáš Tesař, Dragana Atanasijevic, Iga Lipska, Zoltán Kaló

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Introduction: Lower-income European countries have a worse health status and less funds for health care compared to Western Europe. Despite their limited human and financial capacities for conducting Health Technology Assessment (HTA), the need for evidence-based decision-making is growing. Two main approaches emerged as potential solutions: joint clinical assessments on the European level, and simplified procedures relying on the judgments of well-established HTA agencies of Western countries.

Areas covered: Based on considerations of transferability, the European Network for Health Technology Assessment (EUnetHTA) was built up to harmonize HTA methodologies across the European Union, and to develop an HTA Core Model by focusing on joint production of relative effectiveness assessment, which can be used as a basis for national value assessments. The second approach has been suggested in various forms without considering transferability issues.

Expert opinion: Joint clinical assessments reduce duplication of efforts based on appropriate scientific rationale. On the other hand, recent examples show that relying on judgments of HTA agencies from wealthier countries with potentially different health-care priorities can lead to suboptimal allocation decisions. In the short term, some stakeholders may benefit from ignoring transferability, but it will ultimately lead to limited access in other disease areas.

Original languageEnglish
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Volume20
Issue number4
Pages (from-to)321-329
Number of pages10
ISSN1473-7167
DOIs
Publication statusPublished - 2020

Bibliographical note

Published online: 19. June 2020.

Keywords

  • Central and Eastern Europe
  • EUnetHTA
  • Health policy
  • Health technology assessment
  • Transferability

Cite this

Németh, B., Goettsch, W., Kristensen, F. B., Piniazhko, O., Huić, M., Tesař, T., Atanasijevic, D., Lipska, I., & Kaló, Z. (2020). The Transferability of Health Technology Assessment: The European Perspective with Focus on Central and Eastern European Countries. Expert Review of Pharmacoeconomics and Outcomes Research, 20(4), 321-329. https://doi.org/10.1080/14737167.2020.1779061